1.
Azad S, Sood N, Sood A: Biological and histological parameters as predictors of relapse in ulcerative colitis: a prospective study. Saudi J Gastroenterol 2011;17:194-198.
2.
Cons J, Gower-Rousseau C, Seksik P, Cortot A: Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785-1794.
3.
Ahuja V, Tandon RK: Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis 2010;11:134-147.
4.
Ardizzone S, Bianchi Porro G: Comparative tolerability of therapies for ulcerative colitis. Drug Saf 2002;25:561-582.
5.
Papa A, Mocci G, Scaldaferri F, Bonizzi M, Felice C, Andrisani G, Gasbarrini A: New therapeutic approach in inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2009;13(suppl 1):33-35.
6.
Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G: A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Am J Gastroenterol 2004;99:1122-1128.
7.
Lopez-Sanroman A, Bermejo F, Carrera E, Garcia-Plaza A: Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis. Aliment Pharmacol Ther 2004;20:161-166.
8.
Turner D, Walsh CM, Steinhart AH, Griffiths AM: Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 5:103-110.
9.
Fauci A, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J: Harrison's Principles of Internal Medicine, ed 17. New York, Mc Graw Hill Medical Publication, 2008, p 1899.
10.
Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A: Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011. Ergebnisse einer evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2011;49:1276-1341.
11.
Agnivesa, Caraka, D.rdhabala: Caraka Samhitā; chapter 19/69-70; in Vaidya Jādavaji Trikamji Ācārya (ed): Cikitsāsthāna, ed 1. Delhi, Munshiram Manoharlal Publishers, 1981, p 552.
12.
Central Council for Research in Ayurvedic Science: The Ayurvedic Parmacopoeia of India, ed 2012. www.ccras.nic.in/pharmacopoeialwork/links/compfom/ayurvedicfarmocopia.pdf (accessed 22.03.2013).
13.
Walmsley R, Ayres R, Pounder R, Allan R: A simple clinical colitis activity index. Gut 1998;43:29-32.
14.
Powell-Tuck J, Brown RL, Lennard-Jones JE: A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978;13:833-837.
15.
Bhāvamishra: Bhāvaprakāśa Nighaṅtu; edited by Visvanäth Dvivedi, ed 9. Vārān.asi, Motilāl Banärasidāsa Prakāsana, 1998.
16.
Dvivedi V: Bhāvaprakāa Nighaṅtu, ed 9. Väräṇasi, Motilāl Banārasidāsa Prakāśana, 1998.
17.
Digital Helpline for Ayurveda Research Articles (DHARA). www.dharaonline.org (accessed 22.03. 2013).
You do not currently have access to this content.